NOW APPROVED
JIDEYTRO, a new treatment for adults with previously treated ROS1+ NSCLC
is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC) that has spread within the chest or other parts of the body and is caused by an abnormal ROS1 gene, and who have received a ROS1 kinase inhibitor. It is not known if JIDEYTRO is safe and effective in children.
ROS1+=ROS proto-oncogene 1-positive.
Patient portrayal.
Stay updated on JIDEYTRO
Sign up here for more information and occasional updates about JIDEYTRO and ROS1+.